Tofacitinib treatment of alopecia areata may be efficacious for pediatric patients due to rapid regrowth among responders, new findings suggest, though the medication’s durability necessitates additional research.1
These findings followed the conclusion of a recent study authored by Rahul Mahajan, from the department of dermatology, venereology, and leprology at the Post Graduate Institute of Medical Education and Research in India. Mahajan and colleagues noted the need for additional information on the safety and efficacy of oral tofacitinib in pediatric patients with alopecia areata.
“Case reports and small case series highlight the safe and effective use of tofacitinib in children with [alopecia areata],” Mahajan and colleagues wrote. “This retrospective chart review adds to the limited body of evidence,…